TotalMarketCap

Immatics

IMTXNasdaq GermanyHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$929.961 M

$6.22 -10.06%

Close of 6 Nov 2026

As of 6 Nov 2026, Immatics (IMTX) has a market capitalization of $930.0M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

134,071,432

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →
  1. #44Inhibrx BiosciencesINBX$1.18B
  2. #45Vor BiopharmaVOR$1.15B
  3. #46ImmaticsIMTX$930.0M
  4. #47Odyssey TherapeuticsODTX$904.9M
  5. #48Monte Rosa TherapeuticsGLUE$872.8M

What if Immatics were worth as much as…

Open the what-if tool →

Gold $28.2T

$188,709.20

Per share 30,364× higher

Bitcoin $1.53T

$10,210.73

Per share 1,643× higher

Apple $5.02T

$33,520.86

Per share 5,394× higher

Or at a round number

$2.00B$5.00B$10.0B$20.0B

Where these numbers come from

Share counts and financials for Immatics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.